Solve various problems in infectious disease tests such as influenza
M. S. degree from department of Physics, the University of Tokyo. B. S. degree from department of Physics, Tokyo University of Science. Her career includes: Nomura Securities, Co., Ltd. (analyst, Investment Banking division.), Bloomberg LLP (data analyst), Ginza Galleries (International Public Relations/Overseas Project Integration) and Linkers Corporation (Managing Executive Officer). At Linkers Corporation, a start-up company in the technology matching service industry, she won MVP for top sales.
B. S. and M. S. degree from faculty of Materials Engineering, the University of Tokyo (Top Graduate, Dean’s Award). He is currently attending the Ph. D. course at Yoshida lab, faculty of Materials Engineering, Department of Engineering, the University of Tokyo.
Under the supervision of Prof. Yoshida, he is engaged in research on functional polymers, biomaterials, biomimetics, and non-linear non-equilibrium chemistry.
He was awarded the University of Tokyo President’s Award on his research about artificial amoeba utilizing polymeric fluids. In his career, he won more than ten awards at domestic and international conferences including Royal Society of Chemistry Soft Matter Award.
In addition to his research, he established science media and works as a writer collaborating with
B. S. degree from faculty of Chemistry and Biotechnology Engineering, the University of Tokyo. He is currently attending the master course at Nagamune lab., faculty of Chemistry and Biotechnology Engineering, Department of Engineering, the University of Tokyo.
Under the supervision of Prof. Nagamune, he is engaged in research on biotechnology such as cell and protein engineering, and developing a system to detect protein-protein interaction utilizing a cell fate and signaling. In this work, he was awarded Best Oral Presentation Award at The 29th Annual and International Meeting of the Japanese Association for Animal Cell Technology (JAACT 2016).
As an engineer, Nagai has been engaged in general equipment analyses and drug R&D in the field of biochemistry for 12 years at major pharmaceutical companies and a food manufacturer, etc. After graduating from university, she joined a national project team of Keio University. Then, she was engaged in R&D of injectables for hepatitis C and osteoporosis at a major domestic pharmaceutical company, and assessment of adverse drug reaction cases at a foreign pharmaceutical company.
Nagai joined Nanotis due to her deep affinity with our mission concept of “Whenever, Wherever, and Whoever.”
Corporate adviser of Terumo Corporation, Chairman of The Japan Federation of Medical Devices Associations, Chairman of Medical Technology Association of Japan, Director of The Japan Association for Medtech Innovation
B. L. degree from the Faculty of Law, Keio University. Nakao started his career at Terumo Corporation in 1970. Then he successively assumed the posts of Chairman & CEO of Terumo Medical Corporation (US), and Director, Vice President, and Executive Officer at Terumo Corporation. He was then elected as Chairman of the Board of the company in 2011. Since 2016, he has been the Corporate Adviser of Terumo Corporation.
B. S., M. S., and Ph. D. degree from school of Chemical Engineering, Tokyo Institute of Technology in 1973, 1975, and 1985. His career includes: RIKEN (Research Scientist from 1977), University of Illinois (Visiting Researcher from 1988), RIKEN (Vice Senior Research Scientist from 1992), the University of Tokyo (Professor from 1993). Dr. Nagamune is the winner of the 25th Ichimura Award (1993), The SCEJ Award (Tamaki Medal) (2002), Ichimura Prize, IUPAC Fellow on Biotechnology, The SCEJ Award (Ikeda Medal) (2014), etc.
The target of the research group is to invent applications in the field of medical engineering by applying gene engineering, protein engineering, enzyme engineering, etc to biomolecules such as cells or proteins.
National Center for Global Health and Medicine
Disease Control and Prevention Center
Dr. Norio Omagari graduated from Saga Medical School’s Faculty of Medicine, Saga University in 1997.
In the same year, he joined St. Luke’s International Hospital as a resident and then became a general internal medicine staff member. Thereafter, he joined Aida Memorial Hospital in 2001 and the Division of Infectious Diseases at the University of Texas-Houston Medical School in 2002. From 2004 to 2010, he assumed the posts of Senior Staff and Chief in the Division of Infectious Diseases at Shizuoka Cancer Center.
He joined the National Center for Global Health and Medicine and has been the center’s Director since 2012.
Press Release Nanotis (Head Office: Shibuya, Tokyo; CEO, Founder: Lisa Sakashita), the University of Tokyo-related start-up that is developing rapid diagnostic devices for infectious diseases, has raised ¥45,000,000 JPY (~$400,000 USD) from Shizuoka Capital (Head Office: Shizuoka, Shizuoka; President: Akira Hiruma), Hamamatsu Photonics (Head Office: Hamamatsu, Shizuoka; President: Akira Hiruma), […]
第6回DBJ女性新ビジネスプランコンペティションにて、DBJ女性起業優秀賞を受賞しました DBJ女性新ビジネスプランコンペティションは、日本政策投資銀行(DBJ)が執り行う、「革新性や事業性に優れ、発展可能性の高い新ビジネスを対象に行われる、ビジネスプランコンペティション」です。 詳細は日本政策投資銀行のプレスリリースをご覧ください。 2 3 4 5 7
バイエル イノベーション コネクション 2016第 2 回 Grants4Apps Tokyoにて、大賞を受賞しました Grants4Apps Tokyo 2016は、革新的なデジタルヘルステクノロジーを支援するバイエル薬品のオープンイノベーションプログラムです。今回は「ベターライフのための革新的なモニタリングソリューション」をテーマに開催され、ナノティス株式会社の提案したインフルエンザ迅速検診システムが大賞を受賞しました。 詳細はバイエル社のプレスリリースをご覧ください。 1 2 3 4 5